glp-1 nejm Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review The expanding landscape of GLP-1

The current therapeutic paradigm for diabetes management entails a comprehensive, multi-modal strategy encompassing both lifestyle and pharmacological interventions

Adjustments may be needed based on response and side effects

Sun Y, Li J, Sun Y, Zhao R, Wang L, Song W, Wang Z, Wang J, Wei L, Zhao Y, et al

In recent years, GLP-1 receptor agonistsdrugs like Ozempic and Wegovyhave exploded in popularity as effective tools for rapid weight loss

At a Glance: Key Differences At a Glance: Key Differences Insert Figure 1: Side-by-side comparison table of Sermorelin, Ipamorelin, and Tesamorelin

The sweet potato adds complex carbs and fiber